This is the authors' abstract. We don't add key points for this paper.
As in many cancers, genetic analysis of thyroid cancers has identified subgroups that differ in their pathogenesis and has defined targets that make the cancer susceptible to particular therapies. Recent progress leading to new treatments is reviewed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fagin et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: